TECH Straddle Strategy
TECH (Bio-Techne Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands.
TECH (Bio-Techne Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $7.03B, a trailing P/E of 63.87, a beta of 1.41 versus the broader market, a 52-week range of 44.12-72.16, average daily share volume of 2.5M, a public-listing history dating back to 1989, approximately 3K full-time employees. These structural characteristics shape how TECH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.41 indicates TECH has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 63.87 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. TECH pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a straddle on TECH?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current TECH snapshot
As of May 15, 2026, spot at $43.37, ATM IV 55.50%, IV rank 56.70%, expected move 15.91%. The straddle on TECH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on TECH specifically: TECH IV at 55.50% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 15.91% (roughly $6.90 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TECH expiries trade a higher absolute premium for lower per-day decay. Position sizing on TECH should anchor to the underlying notional of $43.37 per share and to the trader's directional view on TECH stock.
TECH straddle setup
The TECH straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TECH near $43.37, the first option leg uses a $43.37 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TECH chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TECH shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $43.37 | N/A |
| Buy 1 | Put | $43.37 | N/A |
TECH straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
TECH straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on TECH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on TECH
Straddles on TECH are pure-volatility plays that profit from large moves in either direction; traders typically buy TECH straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
TECH thesis for this straddle
The market-implied 1-standard-deviation range for TECH extends from approximately $36.47 on the downside to $50.27 on the upside. A TECH long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current TECH IV rank near 56.70% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on TECH should anchor more to the directional view and the expected-move geometry. As a Healthcare name, TECH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TECH-specific events.
TECH straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TECH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TECH alongside the broader basket even when TECH-specific fundamentals are unchanged. Always rebuild the position from current TECH chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on TECH?
- A straddle on TECH is the straddle strategy applied to TECH (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With TECH stock trading near $43.37, the strikes shown on this page are snapped to the nearest listed TECH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are TECH straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the TECH straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 55.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a TECH straddle?
- The breakeven for the TECH straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TECH market-implied 1-standard-deviation expected move is approximately 15.91%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on TECH?
- Straddles on TECH are pure-volatility plays that profit from large moves in either direction; traders typically buy TECH straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current TECH implied volatility affect this straddle?
- TECH ATM IV is at 55.50% with IV rank near 56.70%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.